novel
coronaviru
identifi
caus
pathogen
ongo
outbreak
respiratori
diseas
name
case
sustain
transmiss
occur
china
travelassoci
case
report
countri
includ
europ
itali
sinc
symptom
similar
respiratori
infect
differenti
diagnosi
travel
arriv
countri
widespread
must
includ
common
infect
influenza
respiratori
tract
diseas
follow
first
report
case
acut
respiratori
syndrom
unknown
aetiolog
wuhan
citi
hubei
provinc
decemb
chines
author
identifi
novel
coronaviru
name
sever
acut
respiratori
syndrom
coronaviru
caus
agent
outbreak
spread
rapidli
affect
part
china
case
record
sever
contin
asia
australia
europ
north
america
global
spread
like
occur
spectrum
diseas
human
name
coronaviru
diseas
yet
fulli
determin
confirm
infect
report
ill
rang
peopl
littl
symptom
peopl
sever
ill
pneumonia
die
multipl
bodi
tract
may
involv
includ
respiratori
gastrointestin
musculoskelet
neurolog
tract
howev
common
symptom
fever
cough
short
breath
nonspecif
symptom
share
mani
frequent
infecti
diseas
respiratori
tract
caus
bacteria
virus
selflimit
may
also
progress
sever
condit
among
relev
influenza
usual
characteris
fever
myalgia
headach
nonproduct
cough
may
also
caus
complic
high
morbid
mortal
rate
pneumonia
myocard
central
nervou
system
diseas
death
addit
previous
known
human
coronavirus
caus
similar
although
milder
clinic
sign
includ
alphacoronavirus
betacoronavirus
two
coronavirus
sarscov
merscov
caus
sever
respiratori
syndrom
human
laboratori
virolog
nation
institut
infecti
diseas
lazzaro
spallanzani
inmi
rome
region
refer
centr
emerg
infect
perform
also
diagnost
italian
region
without
diagnost
capabl
emerg
pathogen
earli
januari
follow
announc
emerg
outbreak
laboratori
establish
diagnost
capabl
diagnosi
provid
support
italian
region
focu
result
differenti
diagnosi
perform
first
suspect
case
analys
refer
laboratori
januari
februari
diagnost
algorithm
adopt
laboratori
test
includ
immedi
upon
sampl
receipt
rapid
molecular
test
common
respiratori
pathogen
order
obtain
fast
differenti
diagnosi
test
base
protocol
releas
world
health
organ
three
posit
patient
identifi
time
write
paper
patient
consid
suspect
case
basi
inform
collect
clinic
epidemiolog
ground
ie
suspicion
viral
aetiolog
recent
travel
histori
asia
contact
probabl
confirm
case
accord
guidelin
includ
male
femal
case
italian
citizen
chines
six
nation
mean
age
year
rang
year
nasopharyng
swab
specimen
collect
patient
hospitalis
high
isol
facil
inmi
rome
nine
patient
hospit
lazio
region
case
refer
inmi
laboratori
virolog
differ
region
itali
figur
rapid
differenti
diagnosi
base
qiastatdx
respiratori
panel
qiagen
milan
itali
system
use
singleus
cartridg
includ
reagent
need
nucleic
acid
extract
amplif
detect
common
bacteria
virus
caus
respiratori
syndrom
adenoviru
bocaviru
coronaviru
hcov
coronaviru
hcov
coronaviru
hcov
coronaviru
hcov
human
metapneumoviru
hmpv
influenza
influenza
subtyp
influenza
subtyp
influenza
b
parainfluenza
viru
piv
respiratori
syncyti
viru
ab
rsv
ab
rhinovirusenteroviru
hrvev
bordetella
pertussi
legionella
pneumophila
mycoplasma
pneumonia
result
avail
min
sampl
receipt
result
consid
analysi
includ
suspect
case
undergo
rapid
molecular
test
refer
laboratori
patient
test
laboratori
origin
either
rapid
respiratori
panel
method
among
first
patient
evalu
refer
laboratori
inmi
three
confirm
infect
none
three
coinfect
pathogen
tabl
overal
patient
result
posit
respiratori
pathogen
influenza
virus
repres
major
posit
find
influenza
account
influenza
b
account
singl
infect
virus
repres
well
tabl
far
bacteri
infect
concern
pneumonia
detect
five
patient
l
pneumophila
streptococcu
pneumonia
posit
result
pneumonia
refer
laboratori
origin
found
one
patient
mix
infect
also
observ
small
number
case
tabl
result
highlight
import
differenti
diagnosi
travel
arriv
countri
widespread
occurr
consid
similar
symptom
share
common
respiratori
infect
influenza
respiratori
tract
diseas
broad
screen
respiratori
pathogen
reveal
high
rate
influenza
viru
infect
account
suspect
case
infect
consist
fact
middl
season
influenza
epidem
period
notabl
rapid
influenza
diagnosi
facilit
time
administr
antivir
therapi
thu
reduc
sever
length
diseas
use
unnecessari
antibiot
result
highlight
import
use
broadspectrum
molecular
diagnost
panel
rapid
detect
common
respiratori
pathogen
order
improv
evalu
clinic
manag
patient
respiratori
syndrom
consist
import
epidemiolog
situat
low
circul
altern
diagnos
may
clarifi
individu
patient
risk
may
allow
adjust
public
health
contain
measur
nevertheless
mandatori
maintain
high
level
attent
respect
new
emerg
pathogen
health
author
remain
vigil
increas
capac
surveil
constantli
review
pandem
prepared
plan
